AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2021
Oct 5, 2021
29821_dirs_2021-10-05_5eac5954-97b4-47e8-916c-f21391fdea4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-10-04
Reporting Person: Mahoney Michael F (Director, Chairman, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-04 | Common Stock | M | 134988.0000 | $6.2800 | Acquired | 2216810.0000 | Direct |
| 2021-10-04 | Common Stock | M | 66054.0000 | $7.3900 | Acquired | 2282864.0000 | Direct |
| 2021-10-04 | Common Stock | S | 97838.0000 | $42.4284 | Disposed | 2185026.0000 | Direct |
| 2021-10-04 | Common Stock | S | 103204.0000 | $43.3891 | Disposed | 2081822.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-10-04 | Stock Option (Right to Buy) | $6.2800 | M | 134988.0000 | Disposed | 2022-02-27 | Common Stock (134988.0000) | Direct |
| 2021-10-04 | Stock Option (Right to Buy) | $7.3900 | M | 66054.0000 | Disposed | 2023-02-28 | Common Stock (66054.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F3: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F6: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.